News & Analysis as of

Public Private Partnerships (P3s) Medical Research

Goodwin

Goodwin’s 2025 Rare Disease Symposium: Momentum Builds for Addressing Critical Diagnosis and Treatment Gaps

Goodwin on

Goodwin’s 2025 Rare Disease Symposium, held on February 5 in Boston and virtually, gathered patient advocates and caregivers, providers, researchers, biotech and medtech leaders, investors, and policy experts to discuss the...more

White & Case LLP

Using Data to Combat COVID-19

White & Case LLP on

Data plays a central role in the global efforts to combat the COVID-19 pandemic through virus detection, mitigation of spread, treatments, and vaccines. Public policy responses and private sector initiatives are equally...more

Morrison & Foerster LLP

Other Transactional Authority: A Nontraditional Tool for Partnering with the Federal Government

Last week, the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (“BARDA”) announced that it has used “other transactional authority” to enter into a novel, comprehensive...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide